Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe record history now includes a new revision entry v3.6.6 and the v3.6.5 entry is removed from the list. This updates the visible revision history to reflect the latest changes to the study record.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe study record history adds a new revision entry v3.6.5 and removes the previous v3.6.4 from the list, signaling an update to the page's version history.SummaryDifference0.1%

- Check50 days agoChange DetectedThe study record history now shows Revision: v3.6.4 as the latest entry, replacing the previous Revision: v3.6.3. This reflects an update to the page's revision history without altering the study's data or status.SummaryDifference0.1%

- Check71 days agoChange DetectedA new page revision (v3.6.3) has been posted in the Record History, replacing the previous v3.6.2. This reflects a site update rather than changes to the study details or data.SummaryDifference0.1%

- Check78 days agoChange DetectedA new revision entry (v3.6.2) has been added to the study record history, and the previous revision (v3.6.0) has been removed from the history.SummaryDifference0.1%

- Check93 days agoChange DetectedThe page now includes the links 'Check who can join' and 'Find Contact Information' to help users assess eligibility and contact the study team, and the revision history shows a new 'Revision: v3.6.0' entry alongside the removal of the older 'Revision: v3.5.5'.SummaryDifference0.5%

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.